×
返回 $name
Session Chair(s)
Stacy Tegan
Program Director, Transcelerate Biopharma Inc., United States
Speaker(s)
Ron Fitzmartin, MBA
Principal Consultant, Decision Analytics, United States
FDA Perspective of the Protocol Template
Robert DiCicco, PHARMD
Vice President, Portfolio Management, TransCelerate Biopharma Inc., United States
The Common Protocol Template: Common Structure, Common Language, Uncommon Benefits to End Users
Robert L. Ferendo
Consultant-Process & Technology, Eli Lilly and Company, United States
The Common Protocol Template: Foundation for the Future